EP2265350A1 - Procede de preparation de cristaux a base d'un ester d'acide gras - Google Patents
Procede de preparation de cristaux a base d'un ester d'acide grasInfo
- Publication number
- EP2265350A1 EP2265350A1 EP09732823A EP09732823A EP2265350A1 EP 2265350 A1 EP2265350 A1 EP 2265350A1 EP 09732823 A EP09732823 A EP 09732823A EP 09732823 A EP09732823 A EP 09732823A EP 2265350 A1 EP2265350 A1 EP 2265350A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- flow
- cooling
- fatty acid
- fluid
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- -1 fatty acid ester Chemical class 0.000 title claims abstract description 74
- 235000014113 dietary fatty acids Nutrition 0.000 title claims abstract description 63
- 239000000194 fatty acid Substances 0.000 title claims abstract description 63
- 229930195729 fatty acid Natural products 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 44
- 239000013078 crystal Substances 0.000 title claims abstract description 34
- 239000012530 fluid Substances 0.000 claims abstract description 71
- 239000004615 ingredient Substances 0.000 claims abstract description 43
- 238000001816 cooling Methods 0.000 claims description 86
- 239000000203 mixture Substances 0.000 claims description 72
- 239000004094 surface-active agent Substances 0.000 claims description 55
- 238000009472 formulation Methods 0.000 claims description 44
- 239000000839 emulsion Substances 0.000 claims description 38
- 150000001875 compounds Chemical class 0.000 claims description 34
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 claims description 16
- 238000010791 quenching Methods 0.000 claims description 15
- 230000000171 quenching effect Effects 0.000 claims description 14
- 238000002844 melting Methods 0.000 claims description 13
- 230000008018 melting Effects 0.000 claims description 13
- 238000010899 nucleation Methods 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 12
- 239000012141 concentrate Substances 0.000 claims description 11
- 239000002537 cosmetic Substances 0.000 claims description 10
- 150000004665 fatty acids Chemical class 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 239000002453 shampoo Substances 0.000 claims description 9
- 230000003068 static effect Effects 0.000 claims description 9
- 238000002156 mixing Methods 0.000 claims description 8
- 239000012809 cooling fluid Substances 0.000 claims description 7
- 229920006395 saturated elastomer Chemical group 0.000 claims description 6
- 150000002009 diols Chemical class 0.000 claims description 5
- 229920005862 polyol Polymers 0.000 claims description 5
- 150000003077 polyols Chemical class 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000011144 upstream manufacturing Methods 0.000 claims description 5
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical group C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 claims description 4
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 claims description 4
- 230000000295 complement effect Effects 0.000 claims description 3
- 150000002148 esters Chemical class 0.000 claims description 3
- 238000005187 foaming Methods 0.000 claims description 3
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 claims description 2
- 238000007865 diluting Methods 0.000 claims description 2
- 125000005842 heteroatom Chemical group 0.000 claims description 2
- 150000002430 hydrocarbons Chemical group 0.000 claims 2
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 20
- 150000002191 fatty alcohols Chemical class 0.000 description 16
- 230000008569 process Effects 0.000 description 16
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 14
- 229910052708 sodium Inorganic materials 0.000 description 14
- 239000002280 amphoteric surfactant Substances 0.000 description 13
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 12
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 12
- 239000011734 sodium Substances 0.000 description 12
- 239000013598 vector Substances 0.000 description 12
- 239000003945 anionic surfactant Substances 0.000 description 11
- 239000003795 chemical substances by application Substances 0.000 description 11
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 10
- 150000003839 salts Chemical class 0.000 description 9
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 125000000217 alkyl group Chemical group 0.000 description 8
- 239000002736 nonionic surfactant Substances 0.000 description 8
- 230000003287 optical effect Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- 238000013019 agitation Methods 0.000 description 7
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 7
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 229940093476 ethylene glycol Drugs 0.000 description 6
- 229920001296 polysiloxane Polymers 0.000 description 6
- 239000003381 stabilizer Substances 0.000 description 6
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 5
- 125000002091 cationic group Chemical group 0.000 description 5
- 238000004140 cleaning Methods 0.000 description 5
- 238000009833 condensation Methods 0.000 description 5
- 230000005494 condensation Effects 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 239000011780 sodium chloride Substances 0.000 description 5
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 235000019270 ammonium chloride Nutrition 0.000 description 4
- BTBJBAZGXNKLQC-UHFFFAOYSA-N ammonium lauryl sulfate Chemical compound [NH4+].CCCCCCCCCCCCOS([O-])(=O)=O BTBJBAZGXNKLQC-UHFFFAOYSA-N 0.000 description 4
- 125000000129 anionic group Chemical group 0.000 description 4
- 239000003093 cationic surfactant Substances 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- QTDIEDOANJISNP-UHFFFAOYSA-N 2-dodecoxyethyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOCCOS(O)(=O)=O QTDIEDOANJISNP-UHFFFAOYSA-N 0.000 description 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 239000000498 cooling water Substances 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 150000002462 imidazolines Chemical class 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 239000003921 oil Substances 0.000 description 3
- 235000019198 oils Nutrition 0.000 description 3
- 229940083254 peripheral vasodilators imidazoline derivative Drugs 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 229910021653 sulphate ion Inorganic materials 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 239000004141 Sodium laurylsulphate Substances 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 235000015107 ale Nutrition 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 150000005215 alkyl ethers Chemical class 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 150000005690 diesters Chemical group 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 description 2
- 238000013213 extrapolation Methods 0.000 description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 description 2
- 125000003010 ionic group Chemical group 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 2
- 230000037452 priming Effects 0.000 description 2
- 239000000523 sample Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical class [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 2
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical class OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- XFRVVPUIAFSTFO-UHFFFAOYSA-N 1-Tridecanol Chemical compound CCCCCCCCCCCCCO XFRVVPUIAFSTFO-UHFFFAOYSA-N 0.000 description 1
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 1
- FKKAGFLIPSSCHT-UHFFFAOYSA-N 1-dodecoxydodecane;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC FKKAGFLIPSSCHT-UHFFFAOYSA-N 0.000 description 1
- HBXWUCXDUUJDRB-UHFFFAOYSA-N 1-octadecoxyoctadecane Chemical compound CCCCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCCCC HBXWUCXDUUJDRB-UHFFFAOYSA-N 0.000 description 1
- ALEYBMUCCRAJEB-UHFFFAOYSA-N 2,3-bis(1-phenylethyl)phenol Chemical class C=1C=CC(O)=C(C(C)C=2C=CC=CC=2)C=1C(C)C1=CC=CC=C1 ALEYBMUCCRAJEB-UHFFFAOYSA-N 0.000 description 1
- AZLWQVJVINEILY-UHFFFAOYSA-N 2-(2-dodecoxyethoxy)ethanol Chemical compound CCCCCCCCCCCCOCCOCCO AZLWQVJVINEILY-UHFFFAOYSA-N 0.000 description 1
- KWVPFECTOKLOBL-KTKRTIGZSA-N 2-[(z)-octadec-9-enoxy]ethanol Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCO KWVPFECTOKLOBL-KTKRTIGZSA-N 0.000 description 1
- DWHIUNMOTRUVPG-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-(2-dodecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCO DWHIUNMOTRUVPG-UHFFFAOYSA-N 0.000 description 1
- YPUUGRMTUUCONZ-UHFFFAOYSA-N 2-[dimethyl(octyl)azaniumyl]acetate Chemical compound CCCCCCCC[N+](C)(C)CC([O-])=O YPUUGRMTUUCONZ-UHFFFAOYSA-N 0.000 description 1
- IXOCGRPBILEGOX-UHFFFAOYSA-N 3-[3-(dodecanoylamino)propyl-dimethylazaniumyl]-2-hydroxypropane-1-sulfonate Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC(O)CS([O-])(=O)=O IXOCGRPBILEGOX-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical group OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 1
- 229920002884 Laureth 4 Polymers 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 229920000604 Polyethylene Glycol 200 Polymers 0.000 description 1
- 101000611641 Rattus norvegicus Protein phosphatase 1 regulatory subunit 15A Proteins 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical class OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 229920002359 Tetronic® Polymers 0.000 description 1
- 239000004904 UV filter Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000002877 alkyl aryl group Chemical group 0.000 description 1
- 229940045714 alkyl sulfonate alkylating agent Drugs 0.000 description 1
- 125000005227 alkyl sulfonate group Chemical group 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 150000001649 bromium compounds Chemical class 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229920006317 cationic polymer Polymers 0.000 description 1
- 229960000800 cetrimonium bromide Drugs 0.000 description 1
- 229960002788 cetrimonium chloride Drugs 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical group [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 150000003841 chloride salts Chemical class 0.000 description 1
- 229940096362 cocoamphoacetate Drugs 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 229920006037 cross link polymer Polymers 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- SMVRDGHCVNAOIN-UHFFFAOYSA-L disodium;1-dodecoxydodecane;sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O.CCCCCCCCCCCCOCCCCCCCCCCCC SMVRDGHCVNAOIN-UHFFFAOYSA-L 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 229940085632 distearyl ether Drugs 0.000 description 1
- WSDISUOETYTPRL-UHFFFAOYSA-N dmdm hydantoin Chemical compound CC1(C)N(CO)C(=O)N(CO)C1=O WSDISUOETYTPRL-UHFFFAOYSA-N 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical class CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- SYELZBGXAIXKHU-UHFFFAOYSA-N dodecyldimethylamine N-oxide Chemical compound CCCCCCCCCCCC[N+](C)(C)[O-] SYELZBGXAIXKHU-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 238000007046 ethoxylation reaction Methods 0.000 description 1
- SFNALCNOMXIBKG-UHFFFAOYSA-N ethylene glycol monododecyl ether Chemical compound CCCCCCCCCCCCOCCO SFNALCNOMXIBKG-UHFFFAOYSA-N 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000013020 final formulation Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- WGCNASOHLSPBMP-UHFFFAOYSA-N hydroxyacetaldehyde Natural products OCC=O WGCNASOHLSPBMP-UHFFFAOYSA-N 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 229940048866 lauramine oxide Drugs 0.000 description 1
- 229940100491 laureth-2 Drugs 0.000 description 1
- 229940061515 laureth-4 Drugs 0.000 description 1
- 229940031674 laureth-7 Drugs 0.000 description 1
- 229940094506 lauryl betaine Drugs 0.000 description 1
- 239000004973 liquid crystal related substance Substances 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 239000004530 micro-emulsion Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- DVEKCXOJTLDBFE-UHFFFAOYSA-N n-dodecyl-n,n-dimethylglycinate Chemical compound CCCCCCCCCCCC[N+](C)(C)CC([O-])=O DVEKCXOJTLDBFE-UHFFFAOYSA-N 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- CXQXSVUQTKDNFP-UHFFFAOYSA-N octamethyltrisiloxane Chemical class C[Si](C)(C)O[Si](C)(C)O[Si](C)(C)C CXQXSVUQTKDNFP-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940095127 oleth-20 Drugs 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 238000013341 scale-up Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- KLYDBHUQNXKACI-UHFFFAOYSA-M sodium;2-[2-(2-tridecoxyethoxy)ethoxy]ethyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCOCCOCCOCCOS([O-])(=O)=O KLYDBHUQNXKACI-UHFFFAOYSA-M 0.000 description 1
- 238000007711 solidification Methods 0.000 description 1
- 230000008023 solidification Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 150000003890 succinate salts Chemical class 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 125000005207 tetraalkylammonium group Chemical group 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 230000008719 thickening Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 229940087291 tridecyl alcohol Drugs 0.000 description 1
- ZIBGPFATKBEMQZ-UHFFFAOYSA-N triethylene glycol Chemical compound OCCOCCOCCO ZIBGPFATKBEMQZ-UHFFFAOYSA-N 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000016776 visual perception Effects 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000002888 zwitterionic surfactant Substances 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D9/00—Crystallisation
- B01D9/0004—Crystallisation cooling by heat exchange
- B01D9/0013—Crystallisation cooling by heat exchange by indirect heat exchange
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
- A61Q1/14—Preparations for removing make-up
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q5/00—Preparations for care of the hair
- A61Q5/02—Preparations for cleaning the hair
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/02—Alkyl sulfonates or sulfuric acid ester salts derived from monohydric alcohols
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/22—Amides or hydrazides
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09K—MATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
- C09K23/00—Use of substances as emulsifying, wetting, dispersing, or foam-producing agents
- C09K23/42—Ethers, e.g. polyglycol ethers of alcohols or phenols
Definitions
- the present invention relates to an improved process for preparing a fluid-based, concentrated, fatty acid-based crystal ingredient as well as the use of this fluid concentrated ingredient.
- Crystals of fatty acid esters for example ethylene glycol distearate (or EthyleneGlycol DiSteArate - EGDS) crystals are commonly used in cosmetic formulations, as agents providing some pearlscence and / or as thickening agents and / or as stabilizing agents. These crystals can be formed during the preparation of the cosmetic composition, however for practical and economical reasons they are often marketed in the form of ready-to-use fluid concentrate ingredients intended to be mixed with the other ingredients of the cosmetic formulation.
- ethylene glycol distearate or EthyleneGlycol DiSteArate - EGDS
- DE 3617306 (Henkel) describes a process for the preparation of products based on a fatty acid ester in which a heated emulsion based on the fatty acid ester is cooled slowly without flowing.
- WO9503782 discloses a process for preparing products based on a fatty acid ester in which a heated emulsion based on a fatty acid ester is slowly cooled. Cooling is indicated as up to about 0.25 ° C. per minute (15 ° C. per hour).
- the document US4486334 (Lion) describes a process for the preparation of products based on a fatty acid ester in which a fatty acid ester in liquid-solubilized form is slowly cooled with a surfactant. The cooling method is not indicated. Such a method is impractical and can not be modulated because it strongly depends on the ability to form liquid crystals depending on the surfactants.
- the homogeneity and the kinetics of the cooling process are notably related to the stirring conditions in the reactor.
- the lower the stirring conditions of the medium the longer and less homogeneous the cooling.
- Conducting the entire cooling of the emulsion with stirring can be difficult without significant degradation of the optical properties of the concentrate. In this case it is necessary to practice a part of the cooling in the absence of any agitation to obtain strong pearlescence concentrates.
- This constraint induces, during the industrialization of the process, extrapolation difficulties and significantly hinders productivity.
- the industrial implementation of reactors of 10 to 25 m 3 may require from one to several days to finalize this operation. Such times show low productivity.
- the properties of the concentrates obtained industrially are generally worse than those acquired at the laboratory scale.
- the invention provides a process for preparing a fluid concentrated ingredient comprising crystals based on a fatty acid ester, comprising the following steps: step a) preparing an emulsion comprising water, a compound based on a fatty acid ester, and the surfactant (s), said emulsion being at a temperature above the melting temperature of the compound based on the fatty acid ester, step b) cooling the emulsion at a temperature below the melting temperature of the compound, so as to form the crystals, by implementing at least one cooling phase by introduction of a flow of the emulsion and flow in a cooling device allowing agitation of the flow generated by its own flow, step c) recovering downstream of the cooling device a flow of a fluid comprising the crystals and the surfactant (s), step d) optionally operating a cooling complementary to the fluid step e) optionally adding other compounds to the fluid and / or diluting the fluid and / or mixing the fluid, step f) recovering the concentrated fluid ingredient
- the invention also relates to uses of the products obtained in foaming formulations, especially in cosmetic formulations, typically by mixing with the other ingredients of these formulations.
- the invention also relates to a process for the preparation of such formulations, typically involving a preparation phase of the concentrated fluid ingredient, and then a mixing phase with the other ingredients.
- the method makes it possible to obtain at least one of the following improvements:
- the implementation of the method makes it possible to determine whether the fluid concentrated ingredients prepared at the laboratory scale by the process of the invention can likewise be prepared on an industrial scale. With the aid of the processes of the prior art it can be very long and very difficult, if not impossible, to industrialize fluid concentrated ingredients tested at the laboratory scale.
- the term fluid concentrated ingredient a composition comprising at least 5% by weight of the crystals, preferably at least 10% by weight, preferably less than 35% by weight, typically 15 to 30% by weight for example 15 to 18% or 18 to 22%, or 22 to 26%, or 26 to 30%.
- the ingredient is most often intended to be used for the preparation of cosmetic formulations such as shampoos, after shampoos or shower gels, comprising other ingredients, and more diluted in crystals.
- the term concentrated fluid ingredient is thus particularly used as opposed to finished cosmetic formulations.
- the fluid concentrate ingredient can be referred to as cold pearl concentrate.
- fatty acid ester compound is meant a compound or a composition comprising at least 75% by weight of a fatty acid, and optionally other compounds.
- FIG. 1 represents an embodiment of a cooling device that can be used, alone or in modules, for implementing step b).
- FIG. 2 represents a schematic diagram of a particular embodiment of the method, where quenching is performed, and where step d) and e) are not performed.
- FIG. 3 represents an embodiment of a cooling device using a Sulzer® Mixer Reactor (SMR®) type exchanger.
- SMR® Sulzer® Mixer Reactor
- the fatty acid ester compound is a solid compound at room temperature, preferably at a temperature of 25 ° C. It may especially be a compound whose melting point is greater than 30 ° C., preferably at 40 ° C., preferably at 50 ° C.
- the fatty acid ester on which are the crystals may in particular be a fatty acid ester with a diol or a polyol of formula (I) below:
- R is a linear or branched C 1 -C 21 , preferably C 15 -C 21 , saturated or unsaturated hydrocarbon-based group;
- A is a hydrocarbon group, optionally interrupted by one or more heteroatoms, of valence x + y,
- x is an average number between 1 and 5
- y is an average number of between 0 and 5; x + y is an average number of between 1 and 10, preferably between 2 and 5; In the present application, an average number can designate an integer or a decimal number. In the present application, the expression "between X and Y" includes the terminals X and Y.
- Group A is a group whose compound of formula A - (- OH) x + y is a diol or a polyol. It may especially be a diol such as ethylene glycol, or a polyol such as glycerol. advantageously:
- Group A may in particular present the following formula:
- z identical or different, is an integer from 1 to 10,
- - OE is an optional ethylene oxide group
- n is an average number between 0 and 100, preferably 0 to 10, and
- OP is an optional propylene oxide group
- m is an average number of between 0 and 100, preferably 0 to 10.
- the compound of formula A - (- OH) 2 may be a product of (poly) ethoxylation and / or (poly) propoxylation, or of ethylene glycol condensation and / or propylene glycol.
- the group A does not include EO and / or PO, and it is alkylene CRCI 0, preferably C 2 -C 4.
- the group A can in particular be a methylene, ethylene, propylene or butylene group or a mixture of these groups.
- the R group is a hydrocarbon group, for example an alkyl group, saturated or unsaturated, linear or branched -C 3 -C 2I, preferably C 5 -C 2I. It is an alkyl group corresponding to a fatty acid of formula R-COOH, Ci 4 -C 22 , preferably Ci 6 -C 22 . These fatty acids and alkyl groups are known. These are generally derived from vegetable oils. They can be present in mixtures. In the case of mixtures, the definition of all the groups, irrespective of the number of carbon atoms, if the group (or the corresponding acid) predominates in weight (relative majority, preferably absolute preferably at least 75%) corresponds to the definition.
- the group R may in particular correspond to C1 4 or Ci 6 or Ci 8 or C 22 fatty acid, such as myristic, palmitic, stearic, oleic, erucic or behenic acids.
- R-COO- corresponds to a fatty acid Ci 8, preferably stearic acid. It is particularly advantageous to use a compound based on ethylene glycol distearate (or "Ethylene Glycol Di-Stearate" - EGDS).
- compound “based on ethylene glycol distearate” is meant a compound or a composition comprising at least 75% by weight of ethylene glycol distearate, and optionally other compounds, especially ethylene glycol monostearate (EGMS). .
- EGMS ethylene glycol monostearate
- distearate of ethylene glycol or the acronym EGDS will denote a compound based on ethylene glycol distearate.
- the fatty acid ester comprises at least 80% by weight of ethylene glycol distearate, and optionally ethylene glycol monostearate. It can include:
- ethylene glycol monostearate from 1% to 20% by weight, preferably from 10% to 20%, preferably approximately 15%, of ethylene glycol monostearate.
- the method of the invention uses at least one surfactant.
- the surfactant (s) makes it possible in particular to form the emulsion.
- a surfactant system we implement a single surfactant or several surfactants.
- the surfactant system may in particular comprise a nonionic surfactant and / or anionic surfactant. It is not excluded that it comprises at least one amphoteric surfactant such as betaines (for example alkyldimethylbetins or alkyldimethylamidoalkylbetals) or imidazoline derivatives (for example alkylamphoacetates or alkylamphodiacetates).
- amphoteric surfactant such as betaines (for example alkyldimethylbetins or alkyldimethylamidoalkylbetals) or imidazoline derivatives (for example alkylamphoacetates or alkylamphodiacetates).
- betaines for example alkyldimethylbetins or alkyldimethylamidoalkylbetals
- imidazoline derivatives for example alkylamphoacetates or alkylamphodiacetates.
- the surfactant (s) anionic (s) and / or nonionic (s), it may for example be an ethoxylated fatty alcohol optionally sulfated, such as an ethoxylated fatty alcohol (nonionic surfactant) ) or a sulphated ethoxylated fatty alcohol (anionic surfactant).
- the surfactant is an anionic surfactant, for example a sulphated ethoxylated fatty alcohol, it is generally in the form of a salt, for example a sodium or ammonium salt.
- the surfactant system comprises:
- nonionic surfactant preferably an ethoxylated fatty alcohol
- surfactant preferably selected from anionic surfactants, amphoteric surfactants, nonionic surfactants different from ethoxylated fatty alcohol, and mixtures thereof.
- the surfactant system comprises:
- an anionic surfactant preferably a sulphated ethoxylated fatty alcohol
- Another surfactant preferably selected from nonionic surfactants, amphoteric surfactants, anionic surfactants different from sulfated ethoxylated fatty alcohol, and mixtures thereof.
- ethoxylated fatty alcohols nonionic surfactants
- the fatty alcohols are generally mixtures derived from vegetable products or from petroleum cuts.
- the number of carbon atoms can be an average number or the carbon number of the predominant species.
- These fatty alcohols are ethoxylated.
- the average number by number of ethoxy units may be from 1 to 25, preferably from 5 to 9.5.
- Particularly useful fatty alcohols are ethoxylated fatty alcohols -C 0 -C 4, ethoxylated with an average number as the number of ethoxy units is 5 to 9.5, preferably 5 to 9, for example 7 or 9.
- the anionic surfactant may for example be chosen from saturated or unsaturated, branched or linear alcohols, Ci 0 -Ci 4 ethoxylated and sulfated. It may for example be a tridecyl alcohol preferably ethoxylated branched 2 to 10 times, for example ethoxylated 3 times, and sulfated.
- Rhodapex EST 30 sold by Rhodia (INCI: sodium trideceth-3 sulfate).
- amphoteric surfactant may especially be chosen from alkylamidopropyl betaines, such as cocamidopropyl betaine, and / or imidazoline derivatives, such as alkylamphoacetates or alkylamphodiacetates, in particular lauroamphoacetate or diacetate or cocoamphoacetate or diacetate.
- the fluid concentrated ingredient comprises:
- the amounts of fatty acid ester and surfactant (s) used may be adjusted accordingly during the implementation of the method. It is not excluded to operate, at the end of the process or after, dilutions by adding water or other ingredients.
- the fluidized concentrated ingredient may in particular comprise additives such as preservatives (generally in minor amounts, for example of the order of 0.1% by weight), buffers, stabilizing agents, agents for modifying optical properties.
- the fluid concentrated ingredient may have a viscosity of 10 to 10,000 Pa.s, for example 100 or 500 to 5000 Pa.s at 20 ° C., at a shear of 0.1 s -1 , measured using a plane-plane flow rheometer such as the Rheometrics® ARES equipped with the 50 mm module.
- step a) an emulsion is prepared comprising water, a compound based on a fatty acid ester, and surfactant (s), said emulsion being at a temperature above the temperature melting compound based on the fatty acid ester.
- Step a) may be carried out in known manner by any method for forming an emulsion at a temperature above the melting temperature of the fatty acid ester compound. In particular, it is possible to operate by melting the fatty acid ester and by emulsification in the presence of the surfactant system, subsequently or simultaneously.
- step a) comprises the following steps: a1) preparing a dispersion comprising water, solid particles based on the fatty acid ester, and surfactant (s), a2 ) heating the dispersion so as to liquefy the fatty acid ester-based particles.
- Stage a) may in particular be carried out batchwise, semi-continuously or continuously, preferably in a tank, for example a stirred tank (11).
- the temperature of the emulsion before the cooling step b) is typically greater than or equal to 1 ° C more, preferably at 5 ° C more, preferably at 10 0 C more, than the melting temperature of the fatty acid ester.
- the process is preferably carried out at a temperature greater than or equal to 55 ° C., preferably greater than or equal to 60 ° C., preferably 55 ° C. to 70 ° C., preferably 60 ° C. at 70 0 C or 65 ° C.
- step b) the emulsion is cooled to a temperature below the melting temperature of the compound to form the crystals.
- This step comprises a cooling phase by introduction of a flow of the emulsion (1) and flow in a cooling device (2) allowing agitation of the flow generated by its own flow. All or part of the cooling carried out during step b) can be performed using the cooling device. It is noted that part of the cooling can be implemented by a quenching operation, upstream of the cooling device, in the cooling device, or even downstream. Step b) may include in particular: - optionally a quenching operation, upstream of the cooling device or in the cooling device, where a quenching fluid is mixed with the flow, and / or - optionally an optional seeding operation wherein a seeding fluid comprising crystals based on a fatty acid ester compound is mixed with the stream. Details of quenching and / or seeding operations are given below.
- step b) a flow of material flows into the flow device and this flow is cooled.
- the temperature at the point of introduction of the emulsion is therefore greater than the temperature at the point of exit.
- the flow of material is transformed from an emulsion to a fluid comprising crystals at the outlet of the flow device.
- Step b) is typically operated continuously.
- the cooling carried out in step b) is preferably at least 5 ° C., preferably at least 10 ° C.
- the cooling phase carried out in the flow-through cooling device is preferably at least 5 ° C, preferably at least 10 ° C.
- the flow device typically has a flow zone (3) delimited by so-called confinement walls (4). These delimit the space where the flow flows.
- the flow zone may typically be the inside of a tubular device whose cross-section may be of varied shape, for example round, square, rectangular, ovoid.
- the tube of the tubular device may constitute all of the confinement walls, or part of the confinement walls.
- step b) the flow that flows undergoes agitation generated by the flow itself.
- Simple flow can provide agitation.
- agitation is provided by means of obstacles (5) to the flow. These obstacles are typically provided within the flow zone. These obstacles are preferably static. However, it is not excluded to provide additional agitation with mobile devices such as mobile agitators.
- the obstacles represent a volume of at least 1%, for example from 1 to 5% or from 5 to 10%, or from 10 to 15%, or from 15 to 20%, or from 20 to 25%, or 25 to 30%, or 30 to 40%, or 40 to 50%, or 50 to 75%, of the volume of the flow zone.
- Static or non-static obstacles may in particular be geometric inserts of various shapes.
- the obstacles may also consist of a set of separators and / or flow vein collectors. Cooling inserts within the flow zone can also be used as barriers.
- step b) can be carried out by any appropriate means. Such means are known to those skilled in the art. In particular, it is possible to use a cooling fluid. Such cooling operations and suitable devices are known to those skilled in the art. In particular, tubular exchangers, multitubular exchangers, spiral exchangers, plate exchangers, Sulzer® Mixer Reactor (SMR®) exchangers can be used.
- SMR® Sulzer® Mixer Reactor
- the cooling of step b) may for example be provided by a cooling fluid (6) circulating in a cooling circuit (7).
- the cooling circuit is typically defined by walls, said cooling walls (8), at least a portion of which is in contact with the flow. It is possible to refer to the wall portions in contact with the flow as delimiting a cooling zone. It is noted that the confinement walls and the cooling walls can, on at least a part, constitute a common wall separating the flow zone from the cooling circuit, that is to say separating the flow from the cooling fluid. Note that it may be walls or parts of walls of the same room, or of several parts in contact (for example glued, welded or nested) on the walls or parts of walls. In the embodiment shown in Figure 1 the containment walls (4) and cooling (8) are combined.
- the cooling circuit is placed inside the flow zone, the circuit constituting obstacles to the flow.
- a particular variant of this embodiment is illustrated with reference to FIG. 3.
- SMR® Sulzer® Mixer Reactor
- the cooling circuit is placed outside the flow zone.
- the flow zone may for example consist of at least one tubular duct constituting the confinement walls, provided inside a static mixer, at least a portion of the confinement walls constituting a common wall with at least a part of the cooling circuit.
- the cooling device may for example be a double jacket tubular exchanger, where the cooling circuit is a tubular circuit inside which is disposed an internal tubular duct inside which flow flows.
- a succession of cooling circuits is implemented in which a succession of cooling fluids with equal or variable introduction temperatures, for example increasing or decreasing, flows.
- a succession of cooling fluids with equal or variable introduction temperatures for example increasing or decreasing
- the cooling device of step b) consists of a succession of modules (9) constituting cooling devices as described above.
- Figure 2 illustrates such a particular embodiment.
- the module of (9) may be a device as illustrated in FIG.
- quenching is carried out by mixing a cold quenching fluid (10) at a temperature that is less than or equal to the temperature of the flow at the point where the mixture is blended. preferably less than or equal to the melting point of the fatty acid ester compound.
- This mixing can be carried out upstream of the flow device and / or the flow zone and / or the zone in contact with the cooling circuit, or at a point of the flow situated on the first quarter, of preferably the first eighth, preferably the first sixteenth, of the flow device and / or the flow zone in the cooling device, for example the cooling zone.
- the quenching fluid may especially be at a temperature of less than or equal to 25 ° C.
- the quenching fluid may be pure water or comprising additives.
- the quenching fluid may comprise, as primer or seed, crystals based on the fatty acid ester compound.
- the quenching fluid may be a part of the fluid recovered after steps c), d), or e). Priming or seeding can facilitate the appearance of crystals, and / or promote the production of certain crystalline forms, and thus facilitate the mastery of the optical properties obtained.
- the implementation of a quenching fluid is illustrated in FIG.
- seeding can be carried out by mixing the flow of a seeding fluid at a temperature not lower than or equal to the melting temperature of the fatty acid ester compound. This mixing can be carried out upstream of the flow device and / or the flow zone and / or the zone in contact with the cooling circuit, or at a point of the flow situated on the first quarter, of preferably the first eighth, preferably the first sixteenth, of the flow device and / or the flow zone in the cooling device, for example the cooling zone.
- the seeding fluid comprises, as primer or seed, crystals based on the fatty acid ester compound.
- the seeding fluid may be a part of the fluid recovered after steps c), d), or e).
- Priming or seeding can facilitate the appearance of crystals, and / or promote the production of certain crystalline forms, and thus facilitate the mastery of the optical properties obtained.
- a fluid comprising crystals is mixed, it is a so-called quench fluid fluid or a so-called seeding fluid fluid depending on the temperature.
- the cooling device may in particular be equipped with probes for measuring the temperature and / or the pressure of the flow and / or the temperature of the coolant. Such probes can in particular make it possible to control the process.
- step b) does not cause clogging and shielding phenomena in the flow device, especially in the presence of static mixers.
- fatty acid ester compound of surfactant (s) as follows: a quantity of fatty acid ester compound such as the product recovered in step c) comprises at least 5% by weight, preferably at least 10%, preferably at least 15%, of the fatty acid ester. an amount of surfactant (s) such as the product recovered in stage c) comprises at least 2.5% by weight, preferably 5% by weight, preferably at least 10%; surfactant (s).
- step a) is carried out continuously, discontinuously or sequentially, and
- step b) is implemented continuously.
- a flow of a fluid (13) comprising the crystals and the surfactant (s) is recovered downstream of the cooling device. It can be a flow at room temperature, or a still hot flow.
- a step d) of complementary cooling of the fluid can be implemented in a device with continuous flow, or in a device without flow, statically, discontinuously or semi-continuously.
- Step d) may in particular be carried out in a tank, if necessary agitated, allowing to cool to room temperature, or by controlling the cooling.
- the tank can be cooled with or without cooling means such as jacketed cooling circuits and / or internal coils.
- the additional cooling of step d), after formation of the crystals is less critical for the properties of the concentrated fluid ingredient to be prepared. It can be implemented without affecting productivity and / or properties.
- the fluid comprising the crystals and the surfactant (s) recovered in step c) and / or in step d) may constitute the desired fluid concentrate ingredient.
- the composition of the fluid can be adjusted to obtain the desired fluid concentrate ingredient.
- an optional step e) where other compounds are added to the fluid and / or the fluid is diluted and / or the fluid is mixed.
- step e) it is thus possible to adapt the composition of the fluid concentrate ingredient to the final formulation for which it is intended.
- Step e) can in particular be carried out in a tank, preferably by stirring.
- step e) it is possible in particular to add water or solvents, preservatives, pH control agents, optical property modifiers, suspension stabilizers, other surfactants (or adjust the concentration of the surfactants already present), dispersants.
- steps d) and e) can be implemented simultaneously or subsequently, in order d) then e) or e) then d). It is specified that in the case where steps d) and e) are not performed, steps c) and f) are combined. In steps c) and / or f), for example, the flow and / or the concentrate can be recovered in a vessel and / or in a container (14) allowing transport.
- the method of the invention makes it possible in particular to prepare fluid concentrated ingredients having excellent and stable pearlscence and opacity properties.
- step b) made it possible to conclude that the cooling of the emulsion could not be limited by the heat exchange capacities but could be controlled but by the kinetics of crystallization. In particular, this makes it easier to determine whether the fluid concentrated ingredients prepared at the laboratory scale are industrially feasible, and therefore whether their properties can be preserved during industrial scale-up.
- the fluid concentrated ingredients obtained by the process of the invention can be used in formulations comprising in addition to other ingredients. It is preferably the formulation of consumer products. This may include cosmetic formulations or formulation or home care. These formulations can in particular be foaming formulations. It may for example be products for cleaning dishes by hand or machine. They may also be products for cleaning hard surfaces, for example for cleaning floors or toilets. It may also be formulations for cleaning, care or shaping of the hair, for example in shampoos or hair conditioners, or in cleaning or skin care formulations, for example in gels. shower, hygiene products, makeup removers.
- cosmetic formulations or formulation or home care These formulations can in particular be foaming formulations. It may for example be products for cleaning dishes by hand or machine. They may also be products for cleaning hard surfaces, for example for cleaning floors or toilets. It may also be formulations for cleaning, care or shaping of the hair, for example in shampoos or hair conditioners, or in cleaning or skin care formulations, for example in gels. shower, hygiene products, makeup removers.
- the crystals may especially be used as an agent for modifying the visual perception of the formulation (glossy and / or opaque and / or pearlescent aspect in particular), and / or as an agent for modifying the appearance of the hair (glossy appearance and / or opaque and / or pearlescent in particular), and / or as an agent promoting the suspension (stabilizer for example) of solid or liquid particles (emulsions). It may be in particular a use as a modulating agent brightness and opacity, providing preferably glossy and opaque pearlescent important with reflections of the several colors.
- the amount of fluid concentrated ingredient used may be such that the amount of crystals included in the formulation is less than 5% by weight, typically 1 to 4% by weight.
- the formulations may comprise all the ingredients generally used in the fields of application under consideration.
- the formulations may in particular comprise surfactants.
- cosmetically acceptable vectors in particular aqueous, alcoholic or hydroxyalcoholic vectors,
- nonionic, anionic, cationic, amphoteric surfactants including zwitterionic surfactants
- nonionic, anionic, cationic, amphoteric surfactants including zwitterionic surfactants
- amphoteric surfactants including zwitterionic surfactants
- mixtures thereof in particular those mentioned as being able to be present in the fluid concentrated ingredient, active agents, in solubilized form or in the form of solid or liquid particles, for example anti-dandruff particles, mineral or organic UV filters
- silicones can in particular be in solubilized or dispersed form, in particular dimethicones, amodimethicones, dimethiconols, cationic silicones, silicones comprising polyethylene glycol blocks, in the form of oils, or of emulsion of average size greater or less than at 2 ⁇ m, or in the form of microemulsions smaller than 0.15 ⁇ m, or even in the form of solubilized.
- the emulsification can be carried out in situ or beforehand.
- the viscosity of the silicones may be, for example, less than 50,000 cP, or between 50,000 and 200,000 cP, or greater than 200,000 cP.
- conditioning and / or stabilizing polymers and / or suspending and / or viscosizing agents of natural or synthetic origin in particular:
- cationic or amphoteric polymers such as cationic guars, cationic polysaccharides, for example PQ-10, synthetic cationic polymers such as PQ-7, synthetic amphoteric polymers such as
- thickening and / or stabilizing agents derived from natural polymers such as the optionally partially depolymerized non-grafted guar, hydroxypropyl guars; Xanthan gum,
- - fatty acid esters -C 0 -C 30 preferably C 16 -C 22 and of polyols or monohydric alcohols or ethers of fatty alcohols -C 0 -C 30 preferably a C 6 -C 22 different EGDS, for example distearyl ether, polyethoxylated and / or polypropoxylated stearates or distearates, for example PEG-3 distearates, PEG / PPG distearates, PEG-200 distearates, PEG-150 distearates, PEG-100 stearates
- Cosmetically acceptable vector Any cosmetically acceptable vector for formulating the ampholyte polymer and obtaining the desired cosmetic composition form, for the intended use, may be used. Different cosmetically acceptable vectors for different types of formulations are known to those skilled in the art.
- aqueous vectors comprising water
- alcoholic vectors comprising an alcohol, for example ethanol, isopropanol, ethylene glycol or polyethylene.
- glycol for example ethanol, isopropanol, ethylene glycol or polyethylene glycol
- hydro-alcoholic carriers comprising a mixture of water and an alcohol, for example ethanol, isopropanol, ethylene glycol or polyethylene glycol.
- Some oils, volatile or not, can also be used.
- fluid silicones such as cyclopentasiloxane, for example Mirasil CM5 marketed by Rhodia, are mentioned.
- aqueous vectors are generally used for shampoos or shower gels.
- a propylene glycol vector may be used in the form of creams.
- a cyclomethicone vector can be used for make-up compositions, for example for foundations.
- the formulation may comprise at least one surfactant (iv). It can be a mixture of different surfactants.
- the surfactants may be anionic, cationic, nonionic, amphoteric surfactants or mixtures or combinations.
- the surfactants included in the composition preferably comprise at least one anionic or cationic surfactant.
- the surfactants may also comprise amphoteric surfactants (true or zwitterionic amphoters), neutral surfactants (nonionic surfactants).
- Formulations comprising at least one anionic surfactant and at least one amphoteric surfactant are particularly advantageous, especially for reasons of softness.
- the total content of surfactants in the composition is generally between 0 and 30% by weight.
- the surfactant is preferably absent or present in an amount of less than 5% by weight, and may be preferably a cationic surfactant.
- the surfactant content is advantageously between 10 and 20% by weight.
- Such formulations may comprise salts, for example sodium or ammonium chloride, advantageously in a content of less than 3% by weight.
- the surfactant content is advantageously between 5 and 15% by weight.
- Such formulations also preferably comprise at least 2% by weight of salts, for example sodium or ammonium chloride.
- the surfactant content may be less than 5% by weight.
- the proportion by weight of anionic surfactants relative to all the surfactants is preferably greater than 50%, preferably greater than 70%.
- the anionic surfactants may be chosen from the following surfactants: alkyl ester sulfonates, for example of formula R-CH (SO 3 M) -CH 2 COOR ', or alkyl ester sulfates, for example of formula R-CH (OSO 3 M) - CH 2 COOR ', where R represents a C 8 -C 2 O alkyl radical, preferably C 10 -C 16 alkyl radical, R' a C 1 -C 6 alkyl radical, preferably a dC 3 alkyl radical, and M an alkaline earth metal cation, for example sodium, or the ammonium cation.
- alkyl ester sulfonates for example of formula R-CH (SO 3 M) -CH 2 COOR '
- alkyl ester sulfates for example of formula R-CH (OSO 3 M) - CH 2 COOR '
- R represents a C 8 -C 2 O alkyl radical, preferably C 10
- methyl ester sulfonates whose radical R is C 1 -C 6 ; alkylbenzenesulfonates, more particularly C 9 -C 20 , primary or secondary alkylsulfonates, especially C 8 -C 22 , alkylglycerol sulfonates; alkyl sulphates, for example of formula ROSO 3 M, where R represents a C 1 -C 24 , preferably C 1 -C 20 , alkyl or hydroxyalkyl radical; M a cation of the same definition as above; alkyl ether sulfates, for example of the formula RO (OA) n SO 3 M, where R represents a C 1 -C 24 , preferably C 1 -C 20 , alkyl or hydroxyalkyl radical; OA representing an ethoxylated and / or propoxylated group; M representing a cation of the same definition as above, n generally ranging from 1 to 4,
- the nonionic surfactants may be chosen from the following surfactants: alkoxylated fatty alcohols; for example laureth-2, laureth-4, laureth-7, oleth-20 - alkoxylated triglycerides alkoxylated fatty acids alkoxylated sorbitan esters alkoxylated fatty amines alkoxylated di (1-phenylethyl) phenols - tri (phenyl) The alkoxylated alkyl phenols; the products resulting from the condensation of ethylene oxide with a hydrophobic compound resulting from the condensation of propylene oxide with propylene glycol, such as Pluronic sold by BASF; the products resulting from the condensation of ethylene oxide with the compound resulting from the condensation of propylene oxide with ethylenediamine, such as Tetronic marketed by BASF; alkylpolyglycosides such as those described in US 4565647 or alkylglucosides; fatty acid amides, for
- amphoteric surfactants may be chosen from the following surfactants: betaines in general, in particular carboxybetaines from, for example, lauryl betaine (Mirataine BB from Rhodia) or octylbetaine or cocobetaine (Mirataine BB-FLA from Rhodia); amidoalkyl betaines, such as cocamidopropyl betaine (CAPB) (Mirataine BDJ from Rhodia or Mirataine BET C-30 from Rhodia);
- betaines in general, in particular carboxybetaines from, for example, lauryl betaine (Mirataine BB from Rhodia) or octylbetaine or cocobetaine (Mirataine BB-FLA from Rhodia); amidoalkyl betaines, such as cocamidopropyl betaine (CAPB) (Mirataine BDJ from Rhodia or Mirataine BET C-30 from Rhodia);
- CAPB cocamidopropyl betaine
- sulfobetaines or sultaines such as cocamidopropyl hydroxy sultaine (Mirataine CBS from Rhodia);
- alkylamphoacetates and alkylamphodiacetates such as for example comprising a coco and lauryl chain (Miranol C2M Conc NP, C32 and L32, in particular, from Rhodia);
- alkylamphopropionates or alkylamphodipropionates (Miranol C2M SF); alkyl amphohydroxypropyl sultaines (Miranol CS),
- alkyl amine oxides for example lauramine oxide (INCI).
- the cationic surfactants may be chosen from salts of primary, secondary or tertiary fatty amines, optionally polyethoxylated, quaternary ammonium salts such as chlorides or bromides of tetraalkylammonium, alkylamidoalkylammonium, trialkylbenzylammonium, trialkylhydroxyalkylammonium, or alkylpyridinium, imidazoline derivatives, cationic amine oxides.
- An example of a cationic surfactant is cetrimonium chloride or bromide (INCI).
- Sodium formulations for shampoos typically comprising 12 to 16% by weight of sodium alkylethersulphate (for example sodium laurylethersulphate “SLES”) or of a mixture of sodium alkylethersulfate and sodium alkylsulphate (for example sodium lauryl sulphate “SLS”), 1 to 3% of an amphoteric surfactant (for example cocoamidopropylbetaine "CAPB”), 0.5 to 2% of a salt (for example sodium chloride).
- sodium alkylethersulphate for example sodium laurylethersulphate "SLES”
- SLS sodium lauryl sulphate
- an amphoteric surfactant for example cocoamidopropylbetaine "CAPB”
- CAPB cocoamidopropylbetaine
- Ammonium formulations for shampoos typically comprising 12 to 16% by weight of ammonium alkyl ether sulphate (for example ammonium lauryl ether sulphate “ALES”) or a mixture of ammonium alkyl ether sulphate and alkyl sulphate.
- ammonium for example ammonium lauryl sulphate “ALS”
- a surfactant amphoteric eg cocoamidopropylbetaine "CAPB”
- a salt eg ammonium chloride
- the “sodium" formulations for gel-shower typically comprising 6 to 10% by weight of sodium alkylethersulfate (for example sodium laurylethersulfate “SLES”) or of a mixture of sodium alkylethersulfate and sodium alkylsulphate (for example sodium lauryl sulphate “SLS”), 1 to 3% of an amphoteric surfactant (for example cocoamidopropylbetaine "CAPB”), 2 to 4% of a salt (for example sodium chloride).
- sodium alkylethersulfate for example sodium laurylethersulfate "SLES”
- SLS sodium lauryl sulphate
- an amphoteric surfactant for example cocoamidopropylbetaine "CAPB”
- CAPB cocoamidopropylbetaine
- the "sodium" formulations for gel-shower typically comprising 6 to 10% by weight of ammonium alkylethersulfate (for example ammonium laurylethersulphate)
- ALES ammonium alkylethersulfate and ammonium alkylsulphate
- ALS ammonium laurylsulphate
- an amphoteric surfactant for example cocoamidopropylbetaine "CAPB”
- a salt eg ammonium chloride
- An emulsion having the following composition (quantities by weight of material as is) is prepared in a stirred tank: - EGDS * 23.50%
- the temperature of the emulsion is 65 ° C.
- a piston pump the emulsion is withdrawn from the tank and introduced at 65 ° C in the cooling device described below.
- the device is formed of 6 series of cooling modules of tubular conduits, each consisting of a tubular conduit wrapped by a countercurrent cooling circuit, and provided with a static mixer.
- Figure 1 shows a diagram of a module. The cooling fluid flows from right to left in FIG. 1. The emulsion flows from left to right in FIG. 1. The characteristics of each module are given: - metal tube 15 mm internal diameter.
- the operating conditions of the cooling are as follows:
- a fluid concentrated ingredient having crystals based on EGDS having optical properties (pearlscence) similar to those obtained using a process involving discontinuous crystallization in a batch-type batch reactor is obtained.
- agitated cooled under much lower productivity conditions for example expressed by weight of cooled material per hour and optionally by volume occupied).
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Crystallography & Structural Chemistry (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0802069A FR2929856B1 (fr) | 2008-04-15 | 2008-04-15 | Procede de preparation de cristaux a base d'un ester d'acide gras |
PCT/EP2009/054310 WO2009127596A1 (fr) | 2008-04-15 | 2009-04-09 | Procede de preparation de cristaux a base d'un ester d'acide gras |
Publications (1)
Publication Number | Publication Date |
---|---|
EP2265350A1 true EP2265350A1 (fr) | 2010-12-29 |
Family
ID=40032681
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP09732823A Withdrawn EP2265350A1 (fr) | 2008-04-15 | 2009-04-09 | Procede de preparation de cristaux a base d'un ester d'acide gras |
Country Status (7)
Country | Link |
---|---|
US (1) | US8536356B2 (pl) |
EP (1) | EP2265350A1 (pl) |
JP (1) | JP5684108B2 (pl) |
CN (1) | CN102099089B (pl) |
BR (1) | BRPI0910967A2 (pl) |
FR (1) | FR2929856B1 (pl) |
WO (1) | WO2009127596A1 (pl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2981245B1 (en) | 2013-04-05 | 2023-03-01 | The Procter & Gamble Company | Personal care composition comprising a pre-emulsified formulation |
US10806688B2 (en) | 2014-10-03 | 2020-10-20 | The Procter And Gamble Company | Method of achieving improved volume and combability using an anti-dandruff personal care composition comprising a pre-emulsified formulation |
US9993404B2 (en) | 2015-01-15 | 2018-06-12 | The Procter & Gamble Company | Translucent hair conditioning composition |
EP3405168A1 (en) | 2016-01-20 | 2018-11-28 | The Procter and Gamble Company | Hair conditioning composition comprising monoalkyl glyceryl ether |
CN106382832A (zh) * | 2016-10-17 | 2017-02-08 | 平湖迈柯罗新材料有限公司 | 一种用于剪切变稀型流体的冷凝管 |
CN114191344B (zh) * | 2021-12-19 | 2024-04-12 | 百特威(上海)化妆品有限公司 | 一种用于美白亮肤的化妆品美白乳液制备方法及加工设备 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS57165308A (en) * | 1981-04-03 | 1982-10-12 | Lion Corp | Production of pearlescent dispersion |
US4565647B1 (en) | 1982-04-26 | 1994-04-05 | Procter & Gamble | Foaming surfactant compositions |
JPS61268797A (ja) | 1985-05-23 | 1986-11-28 | ライオン株式会社 | 高濃度真珠様光沢剤分散液の製造方法 |
DE4103551A1 (de) | 1991-02-06 | 1992-08-13 | Henkel Kgaa | Fliessfaehiges perlglanzkonzentrat |
DE4224715A1 (de) * | 1992-07-27 | 1994-02-03 | Hoechst Ag | Fließfähige konservierungsmittelfreie Perlglanzdispersionen |
CA2168346A1 (en) * | 1993-07-28 | 1995-02-09 | Katherine Margaret Wansborough | Pearlescent based concentrate for personal care products |
DE19511571A1 (de) | 1995-03-29 | 1996-10-02 | Henkel Kgaa | Perlglanzkonzentrat mit newton'schem Viskositätsverhalten |
JP3454991B2 (ja) * | 1995-10-13 | 2003-10-06 | 花王株式会社 | パール光沢組成物及びその製造方法 |
DE10005457A1 (de) * | 2000-02-08 | 2001-08-09 | Bayer Ag | Statischer Mischer |
DE10233506B4 (de) * | 2002-07-24 | 2004-12-09 | Bayer Technology Services Gmbh | Mischer/Wärmeaustauscher |
EP1633463B1 (en) * | 2003-05-16 | 2007-10-24 | Velocys Inc. | Process for forming an emulsion using microchannel process technology |
US7485671B2 (en) * | 2003-05-16 | 2009-02-03 | Velocys, Inc. | Process for forming an emulsion using microchannel process technology |
JP3970878B2 (ja) * | 2003-12-10 | 2007-09-05 | 花王株式会社 | 水中油型乳化組成物の製造方法 |
-
2008
- 2008-04-15 FR FR0802069A patent/FR2929856B1/fr not_active Expired - Fee Related
-
2009
- 2009-04-09 WO PCT/EP2009/054310 patent/WO2009127596A1/fr active Application Filing
- 2009-04-09 BR BRPI0910967A patent/BRPI0910967A2/pt not_active IP Right Cessation
- 2009-04-09 JP JP2011504432A patent/JP5684108B2/ja not_active Expired - Fee Related
- 2009-04-09 US US12/937,926 patent/US8536356B2/en not_active Expired - Fee Related
- 2009-04-09 EP EP09732823A patent/EP2265350A1/fr not_active Withdrawn
- 2009-04-09 CN CN200980113368.6A patent/CN102099089B/zh not_active Expired - Fee Related
Non-Patent Citations (1)
Title |
---|
See references of WO2009127596A1 * |
Also Published As
Publication number | Publication date |
---|---|
FR2929856A1 (fr) | 2009-10-16 |
FR2929856B1 (fr) | 2010-08-20 |
JP2011517693A (ja) | 2011-06-16 |
CN102099089B (zh) | 2015-03-25 |
CN102099089A (zh) | 2011-06-15 |
WO2009127596A1 (fr) | 2009-10-22 |
US8536356B2 (en) | 2013-09-17 |
BRPI0910967A2 (pt) | 2016-01-12 |
US20110071308A1 (en) | 2011-03-24 |
JP5684108B2 (ja) | 2015-03-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0767781B1 (fr) | Nouveaux derives d'ammoniums quaternaires, leur procede de preparation et leur utilisation comme agents de surface | |
US7578995B2 (en) | Pearlizer concentrate and its use in personal care compositions | |
EP2136768B1 (en) | Structured surfactant compositions | |
WO2009127596A1 (fr) | Procede de preparation de cristaux a base d'un ester d'acide gras | |
JP6800849B2 (ja) | 第一界面活性剤または第一アニオン性界面活性剤としてアシルグルタミン酸塩を含む組成物 | |
EP2559749A1 (en) | Concentrated liquid detergent composition and process for production thereof | |
CN1203840C (zh) | 清洁组合物 | |
CN104540551A (zh) | 包含氨基酸表面活性剂、甜菜碱和n-甲基-n-酰基葡糖胺的具有更好的泡沫质量和更高粘度的组合物 | |
EP0254653A2 (fr) | Composition détergente, visqueuse, diluable et son procédé d'obtention | |
CH622698A5 (pl) | ||
JP2015500790A (ja) | パーソナルケア組成物での使用のための結晶形成プロセス | |
FR2887450A1 (fr) | Ingredient concentre pour le traitement et/ou la modification de surfaces, et son utilisation dans des compositions cosmetiques | |
EA032874B1 (ru) | Очищающая композиция, содержащая соль ацилглутамата в качестве основного поверхностно-активного вещества или основного анионного поверхностно-активного вещества и специфические структурирующие полимеры | |
JP2001519822A (ja) | 抗菌・抗カビ剤及びリン脂質を含む組成物 | |
FR2934154A1 (fr) | Emulsions thermosensibles | |
CN114423404A (zh) | 预混物和组合物及其制备方法 | |
FR2881348A1 (fr) | Composition cosmetique nettoyante sous forme solide | |
EP1265585B1 (fr) | Emulsion comprenant un systeme huile silicone / co-solvant concentre en matiere(s) active(s) cosmetique(s) liposoluble(s) et formulations cosmetiques correspondantes | |
FR2839308A1 (fr) | Derive de diol et composition le contenant | |
EP0796615A1 (fr) | Composition cosmétique détergente contenant une silicone oxyalkylénée | |
WO1994027574A1 (fr) | Compositions cosmetiques contenant au moins un tensio-actif anionique du type alkylgalactoside uronate et au moins une huile hydrocarbonee synthetique | |
TW202002940A (zh) | 清潔化妝料 | |
EP0736521A1 (fr) | Procédé de purification de tensio-actifs amphotères par électrodialyse | |
EP0624086B1 (fr) | Composition cosmetique destinee a etre additionnee a l'eau d'un bain | |
WO1997000126A1 (fr) | Composition tensioactive a base d'amidoamines polyalcoxylees |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20100923 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK TR |
|
AX | Request for extension of the european patent |
Extension state: AL BA RS |
|
DAX | Request for extension of the european patent (deleted) | ||
17Q | First examination report despatched |
Effective date: 20120312 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61Q 19/10 20060101ALI20151215BHEP Ipc: B01F 17/00 20060101ALI20151215BHEP Ipc: A61Q 5/02 20060101ALI20151215BHEP Ipc: A61K 8/37 20060101AFI20151215BHEP Ipc: B01D 9/00 20060101ALI20151215BHEP Ipc: A61Q 1/14 20060101ALI20151215BHEP |
|
INTG | Intention to grant announced |
Effective date: 20160114 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20160525 |